• HOME
  • ABOUT US
    • ABOUT THE COMPANY
    • THE TEAM
    • CHIEF EXECUTIVE OFFICER
    • CHIEF PHYSICIAN ADVISOR
    • CLINICAL NEUROSCIENCE
    • BIOTECHNOLOGY ADVISOR
    • COMPANY PRESIDENT
    • CHIEF FINANCIAL OFFICER
  • FORZA™
    • ABOUT FORZA™
    • THE STORY
    • THE SOURCE
    • THE PLAN
    • CALORIE RESTRICTION
    • VIRTUAL LIBRARY
  • REVIEWS
    • THE REVIEWS
    • IN LONG COVID
    • IN ALZHEIMER'S DISEASE
    • IN PARKINSON'S DISEASE
    • IN LEWY BODY DEMENTIA
    • IN MULTIPLE SCLEROSIS
    • IN DIABETES
    • IN LUPUS ERYTHEMATOSUS
    • IN SPINAL CORD INJURY
    • IN ARTHRITIS & PAIN
    • IN MIGRAINE & DEPRESSION
    • INFLAMMATION & INSOMNIA
  • WEBINARS
    • WEBINAR GALLERY
    • THE BIOLOGY OF AGING
    • ALZHEIMER'S DISEASE
    • PARKINSON'S DISEASE
    • DEPRESSION
    • FRONTOTEMPORAL DEMENTIAS
    • MULTIPLE SYSTEM ATROPHY
  • CONTACT US
  • Altro
    • HOME
    • ABOUT US
      • ABOUT THE COMPANY
      • THE TEAM
      • CHIEF EXECUTIVE OFFICER
      • CHIEF PHYSICIAN ADVISOR
      • CLINICAL NEUROSCIENCE
      • BIOTECHNOLOGY ADVISOR
      • COMPANY PRESIDENT
      • CHIEF FINANCIAL OFFICER
    • FORZA™
      • ABOUT FORZA™
      • THE STORY
      • THE SOURCE
      • THE PLAN
      • CALORIE RESTRICTION
      • VIRTUAL LIBRARY
    • REVIEWS
      • THE REVIEWS
      • IN LONG COVID
      • IN ALZHEIMER'S DISEASE
      • IN PARKINSON'S DISEASE
      • IN LEWY BODY DEMENTIA
      • IN MULTIPLE SCLEROSIS
      • IN DIABETES
      • IN LUPUS ERYTHEMATOSUS
      • IN SPINAL CORD INJURY
      • IN ARTHRITIS & PAIN
      • IN MIGRAINE & DEPRESSION
      • INFLAMMATION & INSOMNIA
    • WEBINARS
      • WEBINAR GALLERY
      • THE BIOLOGY OF AGING
      • ALZHEIMER'S DISEASE
      • PARKINSON'S DISEASE
      • DEPRESSION
      • FRONTOTEMPORAL DEMENTIAS
      • MULTIPLE SYSTEM ATROPHY
    • CONTACT US
  • HOME
  • ABOUT US
    • ABOUT THE COMPANY
    • THE TEAM
    • CHIEF EXECUTIVE OFFICER
    • CHIEF PHYSICIAN ADVISOR
    • CLINICAL NEUROSCIENCE
    • BIOTECHNOLOGY ADVISOR
    • COMPANY PRESIDENT
    • CHIEF FINANCIAL OFFICER
  • FORZA™
    • ABOUT FORZA™
    • THE STORY
    • THE SOURCE
    • THE PLAN
    • CALORIE RESTRICTION
    • VIRTUAL LIBRARY
  • REVIEWS
    • THE REVIEWS
    • IN LONG COVID
    • IN ALZHEIMER'S DISEASE
    • IN PARKINSON'S DISEASE
    • IN LEWY BODY DEMENTIA
    • IN MULTIPLE SCLEROSIS
    • IN DIABETES
    • IN LUPUS ERYTHEMATOSUS
    • IN SPINAL CORD INJURY
    • IN ARTHRITIS & PAIN
    • IN MIGRAINE & DEPRESSION
    • INFLAMMATION & INSOMNIA
  • WEBINARS
    • WEBINAR GALLERY
    • THE BIOLOGY OF AGING
    • ALZHEIMER'S DISEASE
    • PARKINSON'S DISEASE
    • DEPRESSION
    • FRONTOTEMPORAL DEMENTIAS
    • MULTIPLE SYSTEM ATROPHY
  • CONTACT US

THE SOURCE OF FORZA

Learn more about our Osmotin-rich super plants and view our scientific publications describing their function and enormous potential.

OUR SCIENTIFIC DATA

Our superkiwis over-express the powerful plant protein Osmotin and are the source of our revolutionary product FORZA. 


Our super plants boast over 20 years of R&D and 10 years of field trials performed by our partner University in Italy. 

FORZA™ PRODUCTION

OSMOTIN PRODUCTION

OSMOTIN PRODUCTION

OSMOTIN PRODUCTION

Every cell in our plants produces large amounts of Osmotin making them the perfect source for FORZA™.

HARVESTING

OSMOTIN PRODUCTION

OSMOTIN PRODUCTION

We  harvest the leaves of our Osmotin-rich SUPERKIWI™ plants.

LYOPHILISATION

OSMOTIN PRODUCTION

The leaves are dried to remove excess water and concentrate the Osmotin protein.

FORZA™ POWDER

FORZA™ CAPSULES

The dried leaves are ground to a fine, Osmotin-rich powder.

FORZA™ CAPSULES

FORZA™ CAPSULES

FORZA™ CAPSULES

The powder is encapsulated in industry standard plant-derived gelatine capsules. 

PACKAGING

FORZA™ CAPSULES

FORZA™ CAPSULES

FORZA™ is ready, packaged and shipped.

ICBE 2018 PROCEEDING BOOK

Transformation of kiwi (Actinidia deliciosa A. Chev.) and olive (Olea europaea L.) with tobacco osmotin gene confers drought-stress tolerance and provides a health-promoting protein source.
«The creation of improved plants suitable for adverse abiotic and biotic conditions and the opportunity to also use their leaves and fruits as a source of the health-promoting osmotin protein both provide amazing perspectives for future research in human health and agricultural biotechnology.»

ACTA PHYSIOLOGIAE PLANTARUM, OCT. 2017

Olive (Olea europaea L.) plants transgenic for tobacco osmotin gene are less sensitive to in vitro-induced drought stress


«The transgenic line Canino AT17-1 was more efficient in the activation of defense responses against oxidative stress with respect to the Canino wt.»

KIWINFORMA, OCT. 2016

[ITA]  Strategie per migliorare la tolleranza allo stress idrico dell'Actinidia (Actinidia Deliciosa A. Chev.) e ricerca di marker biochimici per la selezione precoce.


«Questi genotipi sono di fatto dei perfetti bioreattori in grado di fornire l'osmotina, di grande valore terapeutico, in buone quantità e in un contesto già pronto per il consumo umano e animale, rendendo una possibile commercializzazione di questa sostanza economicamente vantaggiosa per l’industria farmaceutica oltre che per i fornitori delle piante.» 


[ENG] Strategies for the improvement of water stress tolerance of actinidia (Actinidia Deliciosa A. Chev) and biochemical marker research for early selection.

 
«These genotypes are, de facto, perfect bioreactors capable of supplying osmotin, of great therapeutic worth, in good quantities and in a context of being ready for human and animal consumption, making the commercialisation of this substance economically advantageous for the pharmaceutical industry and plant suppliers alike.»

VII International Symposium on Kiwifruit, 2011

Kiwifruit Transgenics for Osmotin Gene and Inoculation Tests with Botrytis cinerea and Cadophora luteo-Olivacea
«In particular the transgenic clones 120 and 122 fruits retained higher quality in shelf-life than those harvested from control plants, demonstrating a good resistance to post-harvest damage after a long period of storage.»

DOWNLOAD OUR PUBLICATIONS

Olive Plants Transgenic for tobacco osmotin gene are less sensitive to in-vitro induced drought stress (pdf)

Download

[ITA] Strategie per migliorare la tolleranza allo stress idrico dell'Actinidia (Actinidia Delicio... (pdf)

Download

[ENG] Strategies for the improvement of water stress tolerance of actinidia (Actinidia Deliciosa... (pdf)

Download

Kiwifruit Transgenics for Osmotin Gene and Inoculation Tests with Botrytis cinerea and Cadophora lut (pdf)

Download

ICBE 2018 Proceeding book FULL (pdf)

Download
CONTACT US

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

  • HOME
  • CALORIE RESTRICTION
  • VIRTUAL LIBRARY

Copyright © 2024

9th Dimension Biotech, Inc.

All Rights Reserved.

Gestito da

This site uses cookies to offer you a better browsing experience

We use cookies to analyze website traffic and optimize user experience.
By accepting, you agree that your data will be aggregated with the data of all other users.

Accept